Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGB as Adjuvant to Nimodipine for Vasospasm in Traumatic SAH
NCT04100824Phase 2Completed
- Sponsor
- Assiut University
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in cerebral vasospasm, sponsored by Assiut University. Started Jan 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT04100824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04100824.